2024-06-10 16:00:17
When Olivier Ziegler, head of the Specialised Weight problems Middle (CSO) on the College Hospital Regional Nancy (CHRU) and professor of diet on the College of Lorraine, advised that Stéphane take a look at the brand new weight reduction drug Wegovy, he didn’t hesitate. Second. It is now September 2022. The previous athlete, who stands 1.88 meters tall, stated he had gained weight through the years and his life had develop into extra sedentary. “I wasn’t nervous after I weighed 100 kilograms. At 40, I began affected by hypertension and sleep apnea. I used to be even out of breath to placed on my sneakers. My physique mass index [indice de masse corporelle, soit le poids divisé par la taille au carré]then 41 years outdated.
He learn on the Web: Extreme weight problems. It was a shock to the daddy. His spouse pressured him to go to Nancy CHRU’s CSO. There, his dangerous habits had been scrutinized. “I started to understand what a wholesome way of life is, and the idea of meals is synonymous with reward and the necessity for bodily exercise. I elevated my steps from 2,000 to six,000 steps a day. » Inside 8 months, he misplaced 8 kilograms. Alas, he took them again on trip.
Wegovy actually modified his life. Stéphane misplaced 25 kilograms in 8 months by taking 2.4 milligrams of the drug as a weekly subcutaneous injection. Most significantly, from day one, the sensation of fullness that he had misplaced for years returned. “Earlier than, I used to be by no means full and I may eat three plates of pasta and 4 scrumptious pancakes. My mind did not say ‘cease’, He stated. I may now not differentiate between needs and desires. »
Wegovy is without doubt one of the newest therapeutic advances in treating weight problems. Like its large brother Ozempic (for folks with diabetes), it is a drug that mimics the glucagon-like peptide-1 (GLP-1) hormone, stimulating receptors far more strongly than the pure hormone. This new household of medicine is named “GLP-1 analogues” and primarily consists of semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda has been approved in France since 2021, however will not be reimbursed by social safety).
“Not an urge for food suppressant, not a miracle product”
They have an effect on satiety and due to this fact enable for higher management of meals consumption. “However watch out, these molecules usually are not urge for food suppressants or miracle merchandise.”, warns Karine Clément, professor of diet on the Pitié-Salpêtrière Hospital (AP-HP). Remedy should be complete: modifications in consuming behaviour, bodily exercise, psychological help if essential…” Most medical trials are performed on this foundation.
There are 83.09% left to learn on this article. The rest is reserved for subscribers.
1718049335
#Weight problems #remedy #present process #revolution